DYN
Dyne Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.9% ·
aandelenstroom +28.2% ·
netto nieuwe posities 0.0%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 86 | +1 | 73.72M | $1.63B | +7 | −5 |
| Q1 2026 | 87 | -4 | 78.51M | $1.42B | +7 | −12 |
| Q4 2025 | 92 | 0 | 87.58M | $1.71B | +2 | −1 |
| Q3 2025 | 18 | +1 | 57.06M | $721.88M | +1 | −1 |
| Q2 2025 | 15 | +2 | 34.50M | $328.45M | +2 | — |
| Q1 2025 | 10 | -1 | 12.46M | $130.33M | +1 | −2 |
| Q4 2024 | 11 | 0 | 14.93M | $351.71M | +1 | −1 |
| Q3 2024 | 10 | -2 | 10.58M | $380.14M | +1 | −3 |
| Q2 2024 | 12 | — | 13.13M | $463.42M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 9.76M | +27.6% | $123.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 9.76M | +27.6% | $123.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 9.76M | +27.6% | $123.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passief) | 9.76M | +27.6% | $123.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 9.76M | +27.6% | $123.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 9.63M | +19.3% | $121.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 6.73M | — | $85.14M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 5.40M | +2.0% | $68.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 5.40M | +2.0% | $68.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | Fidelity (FMR) ✦ | 5.40M | +2.0% | $68.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 42 | Fidelity (FMR) ✦ | 5.40M | +2.0% | $68.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 43 | State Street Global Advisors ✦ (passief) | 5.27M | +57.0% | $66.65M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 44 | Adage Capital Partners ✦ | 3.55M | +11.4% | $44.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 45 | Citadel Advisors ✦ | 3.41M | +261.6% | $43.18M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 46 | Citadel Advisors ✦ | 3.41M | +261.6% | $43.18M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 47 | Marshall Wace ✦ | 3.01M | +572.9% | $38.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 48 | Geode Capital Management ✦ (passief) | 2.87M | +27.2% | $36.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 49 | Geode Capital Management ✦ (passief) | 2.87M | +27.2% | $36.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 50 | Goldman Sachs Group ✦ | 1.90M | — | $24.04M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Goldman Sachs Group ✦ | 1.90M | — | $24.04M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Point72 Asset Management ✦ | 1.72M | +1293.4% | $21.73M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 53 | Morgan Stanley ✦ | 1.42M | — | $17.95M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Morgan Stanley ✦ | 1.42M | — | $17.95M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Morgan Stanley ✦ | 1.42M | — | $17.95M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Morgan Stanley ✦ | 1.42M | — | $17.95M | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Morgan Stanley ✦ | 1.42M | — | $17.95M | 0.0% | n/c | 1 | SEC ↗ |
| 58 | Morgan Stanley ✦ | 1.42M | — | $17.95M | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Morgan Stanley ✦ | 1.42M | — | $17.95M | 0.0% | n/c | 1 | SEC ↗ |
| 60 | T. Rowe Price ✦ | 1.40M | -41.4% | $17.69M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 61 | T. Rowe Price ✦ | 1.40M | -41.4% | $17.69M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 62 | Millennium Management ✦ | 413.94K | +190.0% | $5.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 63 | Renaissance Technologies ✦ | 345.50K | Nieuw | $4.37M | 0.0% | New | 1 | SEC ↗ |
| 64 | AQR Capital Management ✦ | 141.88K | +230.6% | $1.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 65 | AQR Capital Management ✦ | 141.88K | +230.6% | $1.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 66 | AQR Capital Management ✦ | 141.88K | +230.6% | $1.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 67 | AQR Capital Management ✦ | 141.88K | +230.6% | $1.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 68 | AQR Capital Management ✦ | 141.88K | +230.6% | $1.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 69 | Wellington Management ✦ | 41.91K | +23.2% | $530,224 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 70 | Wellington Management ✦ | 41.91K | +23.2% | $530,224 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 71 | Wellington Management ✦ | 41.91K | +23.2% | $530,224 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 72 | Wellington Management ✦ | 41.91K | +23.2% | $530,224 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 73 | D. E. Shaw & Co. ✦ | 41.59K | -91.8% | $526,076 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $4.37M | 0.0% |
Verlaten
| Norges Bank | $469,517 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 226 houders, 184.59M aandelen, $2.74B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 1.36M aand · $33.99M
Director · 478.38K aand · $11.96M
Director · 322.46K aand · $8.06M
Director · 63.64K aand · $1.67M
Officer · 1.80K aand · $47,225
Officer · 1.56K aand · $40,892
Officer, Director · 4.99K aand · $131,032
Officer · 226 aand · $5,939
Director · 268.35K aand · $7.03M
Director · 94.42K aand · $2.47M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie